AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

SkinBioTherapeutics Plc

9.5p -$7.25 (-43.28%)
LSE · 16 Sep 2026 08:47 UTC
Previous Close
9.25p
Day Range
9p9.5p
Year Range
0.1p23p
Market Cap
24.62M
AVG Volume
496.87K
Trailing/Forward PE
-52.78/5029.12
PEG ratio
0.01
Dividend Yield
-
Next Earnings Date
2026-12-02
Primary Exchange
London Stock ExchangeUK
Revenue (GBP)
01M2M3M4M20 Q421 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q2
SBTX.L Revenue (GBP) by quarter
PeriodRevenue (GBP)
25 Q22.17M
24 Q43.06M
24 Q21.58M
23 Q41.1M
23 Q2106.58K
22 Q455.07K
22 Q276.98K
21 Q452.81K
21 Q221.95K
20 Q40
Net Income (GBP)
-2M-1M01M20 Q421 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q2
SBTX.L Net Income (GBP) by quarter
PeriodNet Income (GBP)
25 Q2-794.26K
24 Q4337.85K
24 Q2-1.03M
23 Q4-1.54M
23 Q2-1.33M
22 Q4-1.55M
22 Q2-1.29M
21 Q4-1.72M
21 Q2-1.07M
20 Q4-852.39K
Operating Income (GBP)
-2M-1.5M-1M-500K020 Q421 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q2
SBTX.L Operating Income (GBP) by quarter
PeriodOperating Income (GBP)
25 Q2-1.01M
24 Q4-87.59K
24 Q2-1.04M
23 Q4-1.52M
23 Q2-1.39M
22 Q4-1.65M
22 Q2-1.35M
21 Q4-1.82M
21 Q2-1.16M
20 Q4-868.87K
EBITDA (GBP)
-2M-1M01M20 Q421 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q2
SBTX.L EBITDA (GBP) by quarter
PeriodEBITDA (GBP)
25 Q2-757.08K
24 Q4657.8K
24 Q2-881K
23 Q4-1.4M
23 Q2-1.36M
22 Q4-1.62M
22 Q2-1.33M
21 Q4-1.81M
21 Q2-1.14M
20 Q4-865.51K
Cash Flows (GBP)
-2M-1.5M-1M-500K020 Q421 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q2
SBTX.L Cash Flows (GBP) by quarter
PeriodCash Flows (GBP)
25 Q2-1.55M
24 Q4-498.5K
24 Q2-805.85K
23 Q4-1.41M
23 Q2-1.38M
22 Q4-1.79M
22 Q2-1.02M
21 Q4-1.33M
21 Q2-1.44M
20 Q4-950.05K
EPS (GBP)
-0.01-0.01-000.0120 Q421 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q2
SBTX.L EPS (GBP) by quarter
PeriodEPS (GBP)
25 Q2-0
24 Q40
24 Q2-0
23 Q4-0.01
23 Q2-0.01
22 Q4-0.01
22 Q2-0.01
21 Q4-0.01
21 Q2-0.01
20 Q4-0.01
Expenses (GBP)
-2M-1M01M2M3MR&DSG&ACapex20 Q421 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q2
SBTX.L Expenses (GBP) by quarter
PeriodExpenses (GBP)
25 Q22.16M
24 Q4-1.41M
24 Q21.92M
23 Q42.11M
23 Q21.47M
22 Q41.79M
22 Q21.41M
21 Q41.9M
21 Q21.2M
20 Q4927.04K
Cash & Debt (GBP)
02M4M6MCashLong Term DebtShort Term Debt20 Q421 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q2
SBTX.L Cash & Debt (GBP) by quarter
PeriodCash & Debt (GBP)
25 Q23.12M
24 Q44.78M
24 Q21.24M
23 Q4800.9K
23 Q22.84M
22 Q41.31M
22 Q2765.98K
21 Q41.8M
21 Q23.15M
20 Q44.61M
Debt ratios
-0.500.511.520 Q421 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q2
SBTX.L Debt ratios by quarter
PeriodDebt ratios
25 Q20.92
24 Q41.27
24 Q20.04
23 Q4-0
23 Q20.45
22 Q40.21
22 Q20.13
21 Q40.38
21 Q20.9
20 Q41.44
Margins
-50%0%50%100%16 Q421 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q2
SBTX.L Margins by quarter
PeriodMargins
25 Q251.98%
24 Q459.71%
24 Q255.65%
23 Q452.11%
23 Q264.01%
22 Q410.18%
22 Q245.97%
21 Q432.38%
21 Q2-5.41%
16 Q4100%
Return on Capital
-150%-100%-50%0%50%20 Q421 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q2
SBTX.L Return on Capital by quarter
PeriodReturn on Capital
25 Q2-9.96%
24 Q43.59%
24 Q2-23.04%
23 Q4-51.89%
23 Q2-36.56%
22 Q4-77.71%
22 Q2-105.98%
21 Q4-69.39%
21 Q2-25.83%
20 Q4-16.34%
Shares Outstanding
0100M200M300M20 Q421 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q2
SBTX.L Shares Outstanding by quarter
PeriodShares Outstanding
25 Q2258.78M
24 Q4258.78M
24 Q2223.01M
23 Q4195.28M
23 Q2176.89M
22 Q4171.92M
22 Q2156.78M
21 Q4156.78M
21 Q2156.78M
20 Q4156.78M
Book Value Per Share (GBP)
00.010.020.030.0420 Q421 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q2
SBTX.L Book Value Per Share (GBP) by quarter
PeriodBook Value Per Share (GBP)
25 Q20.03
24 Q40.04
24 Q20.02
23 Q40.02
23 Q20.02
22 Q40.01
22 Q20.01
21 Q40.02
21 Q20.03
20 Q40.03
Total Assets (GBP)
05M10M15M20 Q421 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q2
SBTX.L Total Assets (GBP) by quarter
PeriodTotal Assets (GBP)
25 Q29.6M
24 Q412.13M
24 Q27.3M
23 Q45.22M
23 Q24.21M
22 Q42.59M
22 Q21.99M
21 Q43.08M
21 Q24.61M
20 Q45.73M
SkinBioTherapeutics Plc
SBTX.L
Stockpicker

Video analysis: SBTX.L

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.